Toronto Dominion Bank’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-200,800
Closed -$2.12M 2535
2026
Q1
$2.12M Buy
200,800
+10,040
+5% +$106K ﹤0.01% 1124
2025
Q4
$2M Buy
190,760
+15,760
+9% +$164K ﹤0.01% 1119
2025
Q3
$1.81M Sell
175,000
-62,201
-26% -$642K ﹤0.01% 1073
2025
Q2
$2.44M Buy
237,201
+33,496
+16% +$340K ﹤0.01% 918
2025
Q1
$2.05M Buy
+203,705
New +$2.05M ﹤0.01% 932

Other funds holding TDAC

Toronto Dominion Bank's TDAC Position: Q2 2026 in Review

Toronto Dominion Bank sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 200,800 shares — an estimated $2.12M sold.

Toronto Dominion Bank first reported a position in TDAC in Q1 2025 and held it in 5 quarters. The position peaked at $2.44M in Q2 2025. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Toronto Dominion Bank reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • Toronto Dominion Bank sold 200,800 Translational Development Acquisition Corp shares in Q2 2026, an estimated $2.12M.
  • Toronto Dominion Bank first reported a position in Translational Development Acquisition Corp in Q1 2025 and held it in 5 quarters.
  • Toronto Dominion Bank's Translational Development Acquisition Corp position peaked at $2.44M in Q2 2025.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.